ID

41218

Descrição

Feasibility of Assessing Lymphoma Response to Precise Local Injection of Candidate Chemotherapy Agents; ODM derived from: https://clinicaltrials.gov/show/NCT01831505

Link

https://clinicaltrials.gov/show/NCT01831505

Palavras-chave

Versões (1)
  1. 18/07/2020 18/07/2020 -
Titular dos direitos

See clinicaltrials.gov

Transferido a

18 de julho de 2020

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Lymphoma NCT01831505

Inglês

Eligibility Lymphoma NCT01831505

1 Formulários  
  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT01831505
Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
18 years of age or over
Descrição

Age

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001779
has enlarged lymph node(s) highly suspicious of lymphoma; or has been diagnosed with lymphoma but is untreated; or has persistent recurrent, or progressive lymphoma
Descrição

Lymphadenopathy Suspicious Lymphoma | Lymphoma Untreated | Lymphoma Persistent | Recurrent Lymphoma | Lymphoma Progressive

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0497156
UMLS CUI [1,2]
C0750493
UMLS CUI [1,3]
C0024299
UMLS CUI [2,1]
C0024299
UMLS CUI [2,2]
C0332155
UMLS CUI [3,1]
C0024299
UMLS CUI [3,2]
C0205322
UMLS CUI [4]
C4525062
UMLS CUI [5,1]
C0024299
UMLS CUI [5,2]
C0205329
at least one enlarged lymph node that is considered accessible for percutaneous injection by the investigator and that is at least 2 cm in longest dimension.
Descrição

Lymphadenopathy Quantity | Amenable Injection Percutaneous | Lymphadenopathy Longest Diameter

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0497156
UMLS CUI [1,2]
C1265611
UMLS CUI [2,1]
C3900053
UMLS CUI [2,2]
C1533685
UMLS CUI [2,3]
C1522243
UMLS CUI [3,1]
C0497156
UMLS CUI [3,2]
C0552406
ecog performance status of 0-2 (or a karnofsky performance status of >50%).
Descrição

ECOG performance status | Karnofsky Performance Status

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1520224
UMLS CUI [2]
C0206065
labs required for enrollment: absolute neutrophil count > 1000/mm3, platelet count > 50,000/mm3, hematocrit > 25%, creatinine <3.0 mg/dl, total bilirubin <4.0 mg/dl, sgot and sgpt less than five times the institutional upper limits of normal.
Descrição

Laboratory Results Required | Absolute neutrophil count | Platelet Count measurement | Hematocrit level | Creatinine measurement, serum | Serum total bilirubin measurement | Aspartate Aminotransferase Increased | Alanine Aminotransferase Increased

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1254595
UMLS CUI [1,2]
C1514873
UMLS CUI [2]
C0948762
UMLS CUI [3]
C0032181
UMLS CUI [4]
C0518014
UMLS CUI [5]
C0201976
UMLS CUI [6]
C1278039
UMLS CUI [7]
C0151904
UMLS CUI [8]
C0151905
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
lymphoma patients in which the delay of surgery until the lymph node resection date or other factors associated with the study are not feasible.
Descrição

Delay Operative Surgical Procedure

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0205421
UMLS CUI [1,2]
C0543467
patients with central nervous system disease.
Descrição

CNS disorder

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0007682
any therapy that is potentially immunosuppressive or has anticancer activity in the 4 weeks prior to device microinjection.
Descrição

Therapeutic immunosuppression | Cancer treatment

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021079
UMLS CUI [2]
C0920425
patients with active fungal, viral, or bacterial infections
Descrição

Mycoses | Virus Diseases | Bacterial Infections

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0026946
UMLS CUI [2]
C0042769
UMLS CUI [3]
C0004623
pregnant women.
Descrição

Pregnancy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0032961
inability to give informed consent.
Descrição

Informed Consent Unable

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1299582
Voltar ao início da página

Similar models

Eligibility Lymphoma NCT01831505

1 Formulários
  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT01831505
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
18 years of age or over
boolean
C0001779 (UMLS CUI [1])
Lymphadenopathy Suspicious Lymphoma | Lymphoma Untreated | Lymphoma Persistent | Recurrent Lymphoma | Lymphoma Progressive
Item
has enlarged lymph node(s) highly suspicious of lymphoma; or has been diagnosed with lymphoma but is untreated; or has persistent recurrent, or progressive lymphoma
boolean
C0497156 (UMLS CUI [1,1])
C0750493 (UMLS CUI [1,2])
C0024299 (UMLS CUI [1,3])
C0024299 (UMLS CUI [2,1])
C0332155 (UMLS CUI [2,2])
C0024299 (UMLS CUI [3,1])
C0205322 (UMLS CUI [3,2])
C4525062 (UMLS CUI [4])
C0024299 (UMLS CUI [5,1])
C0205329 (UMLS CUI [5,2])
Lymphadenopathy Quantity | Amenable Injection Percutaneous | Lymphadenopathy Longest Diameter
Item
at least one enlarged lymph node that is considered accessible for percutaneous injection by the investigator and that is at least 2 cm in longest dimension.
boolean
C0497156 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C3900053 (UMLS CUI [2,1])
C1533685 (UMLS CUI [2,2])
C1522243 (UMLS CUI [2,3])
C0497156 (UMLS CUI [3,1])
C0552406 (UMLS CUI [3,2])
ECOG performance status | Karnofsky Performance Status
Item
ecog performance status of 0-2 (or a karnofsky performance status of >50%).
boolean
C1520224 (UMLS CUI [1])
C0206065 (UMLS CUI [2])
Laboratory Results Required | Absolute neutrophil count | Platelet Count measurement | Hematocrit level | Creatinine measurement, serum | Serum total bilirubin measurement | Aspartate Aminotransferase Increased | Alanine Aminotransferase Increased
Item
labs required for enrollment: absolute neutrophil count > 1000/mm3, platelet count > 50,000/mm3, hematocrit > 25%, creatinine <3.0 mg/dl, total bilirubin <4.0 mg/dl, sgot and sgpt less than five times the institutional upper limits of normal.
boolean
C1254595 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0948762 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
C0518014 (UMLS CUI [4])
C0201976 (UMLS CUI [5])
C1278039 (UMLS CUI [6])
C0151904 (UMLS CUI [7])
C0151905 (UMLS CUI [8])
Item Group
C0680251 (UMLS CUI)
Delay Operative Surgical Procedure
Item
lymphoma patients in which the delay of surgery until the lymph node resection date or other factors associated with the study are not feasible.
boolean
C0205421 (UMLS CUI [1,1])
C0543467 (UMLS CUI [1,2])
CNS disorder
Item
patients with central nervous system disease.
boolean
C0007682 (UMLS CUI [1])
Therapeutic immunosuppression | Cancer treatment
Item
any therapy that is potentially immunosuppressive or has anticancer activity in the 4 weeks prior to device microinjection.
boolean
C0021079 (UMLS CUI [1])
C0920425 (UMLS CUI [2])
Mycoses | Virus Diseases | Bacterial Infections
Item
patients with active fungal, viral, or bacterial infections
boolean
C0026946 (UMLS CUI [1])
C0042769 (UMLS CUI [2])
C0004623 (UMLS CUI [3])
Pregnancy
Item
pregnant women.
boolean
C0032961 (UMLS CUI [1])
Informed Consent Unable
Item
inability to give informed consent.
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial